T-cell interferon-γ release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings
- 1 May 2009
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Pulmonary Medicine
- Vol. 15 (3), 188-200
- https://doi.org/10.1097/mcp.0b013e32832a0adc
Abstract
The utility of T-cell interferon-gamma (IFN-gamma) responses to Mycobacterium tuberculosis specific antigens [interferon-gamma release assays (IGRAs)] in high-burden settings remains unclear and there is growing evidence that IGRA performance varies across high tuberculosis (TB) burden vs. low TB burden settings. Here we review the evidence supporting the utility of IGRAs in specific subgroups and compare their performance in high-burden vs. low-burden settings. Although the IGRA, compared with the tuberculin skin test (TST), has greater specificity in BCG-vaccinated individuals, treatment of latent tuberculosis infection is not a priority in high-burden setting. Nevertheless, in high-burden settings, the TST performs reasonably well and correlates as well, or better, with proxy measures of exposure. IGRAs may still be useful in high-burden settings in specific subgroups at high risk of progression, including young children, HIV-infected individuals and healthcare workers, but this requires confirmation. Although the IGRAs cannot distinguish between latent and active TB, their utility as rule-out tests, when combined with smear microscopy or the TST, requires further study. Prospective studies are required in high-burden settings to confirm whether IFN-gamma responses are predictive of high risk of progression to active TB, particularly in HIV-infected individuals.Keywords
This publication has 100 references indexed in Scilit:
- Enhancement of Diagnostic Efficiency by a Gamma Interferon Release Assay for Pulmonary TuberculosisClinical and Vaccine Immunology, 2008
- Prevalence of latent tuberculosis infection in German radiologistsJournal of Hospital Infection, 2008
- Comparison of Two Commercially Available Gamma Interferon Blood Tests for Immunodiagnosis of TuberculosisClinical and Vaccine Immunology, 2008
- Performance of an interferon-gamma release assay for diagnosing latent tuberculosis infection in childrenEpidemiology and Infection, 2007
- Response to region of difference 1 (RD1) epitopes in human immunodeficiency virus (HIV)-infected individuals enrolled with suspected active tuberculosis: a pilot studyClinical and Experimental Immunology, 2007
- Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced diseaseClinical and Experimental Immunology, 2007
- Sensitivity of a Whole-Blood Interferon-Gamma Assay Among Patients with Pulmonary Tuberculosis and Variations in T-Cell Responses During Anti-Tuberculosis TreatmentInfection, 2007
- Serial Testing of Health Care Workers for Tuberculosis Using Interferon-γ AssayAmerican Journal of Respiratory and Critical Care Medicine, 2006
- Sensitivity Analysis and Potential Uses of a Novel Gamma Interferon Release Assay for Diagnosis of TuberculosisJournal of Clinical Microbiology, 2006
- Performance of a whole blood interferon gamma assay for detecting latent infection with Mycobacterium tuberculosis in childrenThorax, 2006